WallStreetZenWallStreetZen

NASDAQ: GOVX
Geovax Labs Inc Stock Forecast, Predictions & Price Target

Analyst price target for GOVX

Based on 1 analyst offering 12 month price targets for Geovax Labs Inc.
Min Forecast
$120.00+8,119.18%
Avg Forecast
$120.00+8,119.18%
Max Forecast
$120.00+8,119.18%

Should I buy or sell GOVX stock?

Based on 1 analyst offering ratings for Geovax Labs Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their GOVX stock forecasts and price targets.

GOVX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-11-13

1 of 1

Forecast return on equity

Is GOVX forecast to generate an efficient return?

Forecast return on assets

Is GOVX forecast to generate an efficient return on assets?

GOVX revenue forecast

What is GOVX's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$133.5M
Avg 2 year Forecast
$26.9M
Avg 3 year Forecast
$63.8M

GOVX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
GOVX$1.46$120.00+8,119.18%Buy
FRES$0.35N/AN/A
BPTS$0.29N/AN/A
PHIO$0.65$4.00+516.33%Buy
SXTP$0.25N/AN/A

Geovax Labs Stock Forecast FAQ

Is Geovax Labs Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: GOVX) stock is to Buy GOVX stock.

Out of 1 analyst, 0 (0%) are recommending GOVX as a Strong Buy, 1 (100%) are recommending GOVX as a Buy, 0 (0%) are recommending GOVX as a Hold, 0 (0%) are recommending GOVX as a Sell, and 0 (0%) are recommending GOVX as a Strong Sell.

If you're new to stock investing, here's how to buy Geovax Labs stock.

What is GOVX's revenue growth forecast for 2026-2028?

(NASDAQ: GOVX) Geovax Labs's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.32%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.27%.

Geovax Labs's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast GOVX's revenue for 2026 to be $289,998,312, with the lowest GOVX revenue forecast at $289,998,312, and the highest GOVX revenue forecast at $289,998,312. On average, 1 Wall Street analysts forecast GOVX's revenue for 2027 to be $58,368,949, with the lowest GOVX revenue forecast at $58,368,949, and the highest GOVX revenue forecast at $58,368,949.

In 2028, GOVX is forecast to generate $138,656,122 in revenue, with the lowest revenue forecast at $138,656,122 and the highest revenue forecast at $138,656,122.

What is GOVX's forecast return on assets (ROA) for 2026-2027?

(NASDAQ: GOVX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is GOVX's Price Target?

According to 1 Wall Street analyst that have issued a 1 year GOVX price target, the average GOVX price target is $120.00, with the highest GOVX stock price forecast at $120.00 and the lowest GOVX stock price forecast at $120.00.

The Wall Street analyst predicted that Geovax Labs's share price could reach $120.00 by Nov 13, 2024. The average Geovax Labs stock price prediction forecasts a potential upside of 8,119.18% from the current GOVX share price of $1.46.

What is GOVX's forecast return on equity (ROE) for 2026-2027?

(NASDAQ: GOVX) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.